Table 3.

Outcomes in patients undergoing percutaneous coronary intervention (PCI) randomized to an acute pre-procedural oral load of colchicine or placebo

	Colchicine (n=206)	Placebo (n=194)	p-value
Primary outcome
PCI-related myocardial injury	118 (57.3)	122 (64.2)	0.19
Secondary outcomes
30-day major adverse cardiovascular events	24 (11.7)	25 (12.9)	0.82
Type 4a myocardial infarction (Universal Definition)	23 (11.2)	23 (12.1)	0.89
Type 1 myocardial infarction (Universal Definition)	0	1 (0.5)	0.49
Target vessel revascularization	0	0	--
All-cause mortality	1 (0.5)	1 (0.5)	0.99
PCI-related myocardial infarction (SCAI definition)	6 (2.9)	9 (4.7)	0.49

Data are presented as frequency (proportion) and compared using chi-square test, or fisher’s exact test if the cell number is less than 5.